ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin‐bound paclitaxel with or without CC‐486 as second‐line treatment for advanced nonsquamous non‐small cell lung cancer (NSCLC)

<p><strong>Background</strong> This randomized phase 2 trial compared the efficacy and safety of second‐line nanoparticle albumin‐bound paclitaxel (nab‐paclitaxel) with or without the addition of CC‐486 (an oral formulation of 5‐azacytidine) in patients with advanced‐stage, nonsqua...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Morgensztern, D, Cobo, M, Ponce Aix, S, Postmus, PE, Lewanski, CR, Bennouna, J, Fischer, JR, Juan-Vidal, O, Stewart, DJ, Fasola, G, Ardizzoni, A, Bhore, R, Wolfsteiner, M, Talbot, DC, Jin Ong, T, Govindan, R, On Behalf Of The Abound L Investigators
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Wiley 2018

Παρόμοια τεκμήρια

ABOUND.2L+: nab-paclitaxel (nab-P) +/- CC-486 or durvalumab in previously treated patients with advanced non-small cell lung cancer (NSCLC)
ανά: Morgensztern, D, κ.ά.
Έκδοση: (2017)

Efficacy and safety of second- or third-line nab-paclitaxel + durvalumab in patients with advanced NSCLC (ABOUND.2L+)
ανά: Morgensztern, D, κ.ά.
Έκδοση: (2018)

Quality of life in patients with advanced NSCLC treated in second- or third-line with nab-paclitaxel + durvalumab: abound.2l+
ανά: Talbot, D, κ.ά.
Έκδοση: (2018)

Nab-paclitaxel + durvalumab as second- or third-line treatment of advanced NSCLC: results from ABOUND.2l+
ανά: Govindan, R, κ.ά.
Έκδοση: (2017)

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
ανά: Daniel Morgensztern, κ.ά.
Έκδοση: (2021-02-01)

Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer
ανά: Ponce Aix, S, κ.ά.
Έκδοση: (2020)

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC
ανά: Corey J. Langer, κ.ά.
Έκδοση: (2018-07-01)

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis
ανά: Corey J. Langer, κ.ά.
Έκδοση: (2021-01-01)

Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies.
ανά: Eric Laille, κ.ά.
Έκδοση: (2015-01-01)

nab-Paclitaxel–Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2
ανά: Ajeet Gajra, κ.ά.
Έκδοση: (2018-07-01)

The uses of anxiety: Grace Abounding to the Chief of Sinners (1666)
ανά: Seymour, L
Έκδοση: (2023)

Short Toxin-like Proteins Abound in Cnidaria Genomes
ανά: Michal Linial, κ.ά.
Έκδοση: (2012-11-01)

Misperceptions of "light" cigarettes abound: National survey data
ανά: Thomson George, κ.ά.
Έκδοση: (2009-05-01)

Aboundance, Diversity and Distribution of Ichthyoplanktons in Creeks and Coastal Waters of Khouzestan Province
ανά: S. Dehghan; A. Savari; P. Kochenin; J. Ghafle marammazi
Έκδοση: (1999-01-01)

The Jurisdictional Basis, Elements and Remedies in the Action for Breach of Confidence - Uncertainty Abounds
ανά: Leo Tsaknis

Features of fibrosis regression abound in "non-cirrhotic" patients with resected hepatocellular carcinoma.
ανά: Christine E Orr, κ.ά.
Έκδοση: (2022-01-01)

Improbabilities abound”: Daphne du Maurier’s Rule Britannia and the speculative political future
ανά: Aoife Byrne
Έκδοση: (2015-07-01)

Features of fibrosis regression abound in “non-cirrhotic” patients with resected hepatocellular carcinoma
ανά: Christine E. Orr, κ.ά.
Έκδοση: (2022-01-01)

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
ανά: Véronique Hofman, MD, PhD, κ.ά.
Έκδοση: (2023-02-01)

Phase III, randomized, placebo-controlled trial of CC-486 (Oral Azacitidine) in patients with lower-risk myelodysplastic syndromes
ανά: Garcia-Manero, G, κ.ά.
Έκδοση: (2021)

An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
ανά: Neda Stjepanovic, κ.ά.
Έκδοση: (2020-10-01)

Exodus, Psalms and Hebrews: A God abounding in steadfast love (Ex 34:6)
ανά: Alphonso Groenewald
Έκδοση: (2008-03-01)

Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge
ανά: Jun Sugisaka, κ.ά.
Έκδοση: (2023-11-01)

Ticks and Tick-Borne Pathogens Abound in the Cattle Population of the Rabat-Sale Kenitra Region, Morocco
ανά: Latifa Elhachimi, κ.ά.
Έκδοση: (2021-12-01)

Soils rich in biological ice-nucleating particles abound in ice-nucleating macromolecules likely produced by fungi
ανά: F. Conen, κ.ά.
Έκδοση: (2018-07-01)

Length Frequency, Sex Ratio and Relative Aboundance (CPUE) of Astacus leptoductylus in Arass Reservior (1997-98)
ανά: M. Karimpor; N. Hosseinpor
Έκδοση: (1999-01-01)

Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial
ανά: Yoshimasa Shiraishi, κ.ά.
Έκδοση: (2022-09-01)

Computer processor unit 486
ανά: Universiti Teknologi Malaysia. Perpustakaan
Έκδοση: (1989)

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
ανά: Gridelli C, κ.ά.
Έκδοση: (2018-05-01)

Androgen Receptor Expression in Primary Nonsquamous Cell Rare-Variant Carcinomas of the Head and Neck
ανά: Siavash Rahimi MD, FRCPath, κ.ά.
Έκδοση: (2017-06-01)

Multicenter study of carbon‐ion radiation therapy for nonsquamous cell carcinomas of the oral cavity
ανά: Hiroaki Ikawa, κ.ά.
Έκδοση: (2019-09-01)

A Real-World Study on the Effectiveness and Safety of Pembrolizumab Plus Chemotherapy for Nonsquamous NSCLC
ανά: Daichi Fujimoto, MD, κ.ά.
Έκδοση: (2022-02-01)

Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
ανά: Hidetoshi Hayashi, κ.ά.
Έκδοση: (2011-01-01)

P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
ανά: Maria Amaya, κ.ά.
Έκδοση: (2023-08-01)

KIE 486 - KIMIA MAKANAN JUN 1994.
ανά: PPSK, Pusat Pengajian Sains Kimia
Έκδοση: (1994)

Brief Report: Impact of Maintenance Pemetrexed Cessation on Clinical Outcomes of Patients With Metastatic Nonsquamous NSCLC
ανά: Shreya Bhatia, BS, κ.ά.
Έκδοση: (2024-11-01)

Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021
ανά: Lisa M. Hess, PhD, κ.ά.
Έκδοση: (2022-06-01)

Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience
ανά: Laurent Greillier, κ.ά.
Έκδοση: (2016-10-01)

An Epidemiologic study of Oral and Pharyngeal Nonsquamous Cell Malignant Tumors inKerman province, Iran
ανά: MR. Zarei, κ.ά.
Έκδοση: (2007-03-01)

Glenn's Suzuki one-cylinder repair and tune-up guide : models 50 cc, 55 cc, 80 cc, 90 cc, 120 cc, 125 cc, 185 cc, 250 cc, 400 cc/
ανά: 402466 Crawford, Charles W., κ.ά.
Έκδοση: (1972)